Elevation Wealth Partners’s Chemours CC Stock Holding History
Bought
Maintained
Sold
Other funds holding CC
Elevation Wealth Partners's CC Position: Q3 2026 in Review
Elevation Wealth Partners increased its Chemours (CC) stake by 273% in Q3 2026, buying an estimated $1.14K and bringing the position to 97 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.
Elevation Wealth Partners first reported a position in CC in Q1 2026 and has held it in 3 quarters since. 143 funds tracked by Wall St. Rank hold CC as of Q3 2026.
- Elevation Wealth Partners held 97 shares of Chemours worth $1.32K as of Q3 2026.
- Elevation Wealth Partners bought 71 Chemours shares in Q3 2026, an estimated $1.14K.
- Chemours made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1287 holding.
- Elevation Wealth Partners first reported a position in Chemours in Q1 2026 and has held it in 3 quarters since.
- 143 funds tracked by Wall St. Rank held Chemours as of Q3 2026.
Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.